Axogen (AXGN) analyst forecast and price target
Analyst forecast
Consensus of 11 analyst ratings
Based on 4 analyst targets
Recent analyst ratings
| Firm | Action | Rating | Price target | Date |
|---|---|---|---|---|
| Truist Securities | Initiated Coverage | Buy | $60.00 | Aug 26, 2026 |
| HC Wainwright & Co. | Maintained | Buy | $53.00 from $50.00 | Jul 30, 2026 |
| Canaccord Genuity | Maintained | Buy | $55.00 from $50.00 | Jul 30, 2026 |
| Citizens | Maintained | Market Outperform | $55.00 from $50.00 | Jul 30, 2026 |
| HC Wainwright & Co. | Maintained | Buy | $50.00 from $39.00 | Apr 29, 2026 |
| Wells Fargo | Maintained | Overweight | $48.00 from $40.00 | Apr 29, 2026 |
| Canaccord Genuity | Maintained | Buy | $50.00 from $45.00 | Apr 29, 2026 |
| Citizens | Maintained | Market Outperform | $50.00 from $42.00 | Apr 29, 2026 |
| Lake Street | Maintained | Buy | $50.00 from $40.00 | Apr 23, 2026 |
| Canaccord Genuity | Maintained | Buy | $40.00 | Mar 30, 2026 |
| Citizens | Maintained | Market Outperform | $42.00 from $34.00 | Feb 24, 2026 |
| Wells Fargo | Initiated Coverage | Overweight | $40.00 | Feb 19, 2026 |
| HC Wainwright & Co. | Maintained | Buy | $39.00 from $26.00 | Dec 5, 2025 |
| Canaccord Genuity | Maintained | Buy | $37.00 from $27.00 | Dec 5, 2025 |
| Lake Street | Maintained | Buy | $40.00 from $30.00 | Dec 4, 2025 |
| Jefferies | Maintained | Buy | $36.00 from $29.00 | Dec 4, 2025 |
| Mizuho | Initiated Coverage | Outperform | $40.00 | Dec 1, 2025 |
| Canaccord Genuity | Maintained | Buy | $27.00 from $24.00 | Oct 30, 2025 |
| Raymond James | Maintained | Outperform | $27.00 from $20.00 | Oct 30, 2025 |
| HC Wainwright & Co. | Maintained | Buy | $26.00 from $25.00 | Oct 30, 2025 |
Frequently asked questions
What is the price target for AXGN stock?
The average 12-month analyst price target for Axogen (AXGN) is $55.75, with a high estimate of $60.00 and a low of $53.00, across 4 analysts.
Is AXGN a buy, sell, or hold?
Analysts covering Axogen currently average a Buy rating: 10 buy, 1 hold and 0 sell, from 11 analysts. Ratings reflect analyst opinion, not investment advice.
What upside do analysts see for AXGN?
The average price target of $55.75 implies 9.70% upside from the last price of $50.82.
What is the latest analyst rating on AXGN?
On Aug 26, 2026, Truist Securities initiated coverage of Axogen at Buy with a price target of $60.00.
Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.